Last reviewed · How we verify
NCT04702113: CARES2
Evaluating Pharmacogenomic Variants for Cardiology Therapeutics
NA trial testing Cipherome Lighthouse Pilot in Thrombosis in 300 participants. Completed in 27 July 2023.
26 July 2023
Quick facts
| Lead sponsor | Cipherome, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | diagnostic |
| Enrollment | 300 |
| Start date | 3 December 2020 |
| Primary completion | 26 July 2023 |
| Estimated completion | 27 July 2023 |
| Sites | 1 location across United States |
Drugs / interventions tested
- Cipherome Lighthouse Pilot
Conditions studied
- Thrombosis — all drugs for Thrombosis →
- Stent Thrombosis — all drugs for Stent Thrombosis →
- Bleeding — all drugs for Bleeding →
- Myocardial Infarction — all drugs for Myocardial Infarction →
Sponsor
Cipherome, Inc.
Who can join
Adults 18 to 99, any sex, with Thrombosis or Stent Thrombosis. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Cipherome's Lighthouse is a clinical decision support tool that incorporates a patient's pharmacogenetic information to determine therapeutic strategy, including determining appropriate dosage or assessing the likelihood of toxicity of a therapeutic regimen.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04702113
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Thrombosis
Currently open trials in the same condition.
- NCT07137429 — Platelet Volunteers, Longitudinal and Multi-omic Study · recruiting
- NCT06676904 — Neonatal Platelet Transfusion Threshold Trial · NA · recruiting
- NCT06993740 — Effect of Dexmedetomidine on Microsurgery Reconstruction in Cancer Patient · NA · recruiting
- NCT07358416 — Complications and Antiplatelet and Anticoagulant Therapy in Vascular Surgery. · active not recruiting
- NCT06370273 — Thromboprophylaxis in Lower Limb Immobilisation · Phase 3 · recruiting
Other Cipherome, Inc. trials
Trials by the same sponsor.
- NCT04770922 — Pharmacogenomic Analysis in Pediatric Acute Lymphoblastic Leukemia · completed
- NCT04580589 — DOAC ADRs Retrospective Study on Genetic Variations · completed
- NCT04597593 — Association Between Genetic Variant Scores and DOACs (DARES2) · completed
- NCT04580602 — Association Between Genetic Variant Scores and P2Y12 Inhibitor Effects · completed
- NCT04247919 — DOAC ADRs Retrospective Study · terminated
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04702113 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Cipherome, Inc.
- Last refreshed: 29 September 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04702113.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing